MicroCures
Business Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1300 Morris Park Ave Ste 7, Bronx, New Y...Phone Number
(650) 387-2653Website
www.microcures.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About MicroCures
MicroCures is a biotechnology company focused on developing pro-regenerative siRNA therapies that enhance the body's natural healing processes. Their innovative approach targets intracellular barriers to repair, specifically silencing the FL2 enzyme to promote tissue and nerve regeneration. The company aims to provide effective treatment options for conditions like neurotrophic keratitis and other applications involving nerve and wound healing. MicroCures seeks collaboration with researchers, clinicians, and investors to advance their mission of restoring the body's intrinsic ability to heal.Explore more
MicroCures Org Chart
AK
Director of Tissue Regeneration and Repair
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is MicroCures your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if MicroCures had a recent Job posting/layoffs
Earning: See what the market has to say on MicroCures recently announced quarterly report
Check out if MicroCures is spiking on competitors!
Product Launch: Get notified when MicroCures launches new products
Website visits: Recent activity has been detected on your website
Check if MicroCures has recently received funding, and reach out quickly before it becomes old news!
MicroCures, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once MicroCures has new funding data
Congratulate Masked Content for being promoted to Masked Content at MicroCures
Recommended Actions
Reach out to Masked Content who joined MicroCures as Masked Content
Find more new buyers
Compare Similar Companies to MicroCures
Compare insights from companies similar to MicroCures, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
MicroCures is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
MicroCures is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about MicroCures.
MicroCures Tech Stack
A closer look at the technologies used by MicroCures
See more technologies
MicroCures News & Media
MicroCures Announces Material Transfer Agreement with Henry M. Jackson Foundation for the Advancement of Military Medicine to Support Preclinical Study of siFi2 for Spinal Cord Regeneration Following Injury
U.S. Department of Defense Researchers to Study Ability of siFi2 to Drive Axon Regeneration and Functional Recovery following Spinal Cord Injury U.S. Department of Defense Researchers to Study Ability of siFi2 to Drive Axon Regeneration and Functional Recovery following Spinal Cord InjuryMicroCures Advances Burn Wound Healing Program Under Cooperative Research and Development Agreement (CRADA) with the U.S. Army Institute of Surgical Research (USAISR)
$1 Million in Funding from the USAISR Supporting Collaborative Research ProjectMicroCures Announces Issuance of New Patent Covering First-of-its-Kind Cell Movement Decelerator Technology with Potential Applications in Oncology and Fibrosis
New Japanese Patent Further Strengthens Intellectual Property Portfolio Covering Company’s Novel Platform for Precisely Controlling Core Cell Migration MechanismsMicroCures Awarded $1.5M SBIR Grant To Support Development of Novel Therapeutic Platform for Accelerated Tissue Repair
Funding to Support Ongoing Advancement of siFi2, Lead Candidate from Company’s First-of-its-Kind Platform for Precisely Controlling Core Cell Migration Mechanisms Funding to Support Ongoing Advancement of siFi2, Lead Candidate from Company’s First-of-its-Kind Platform for Precisely Controlling Core Cell Migration Mechanisms
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MicroCures
Sign Up For FreeTo access detailed company insights
MicroCures is a biotechnology company focused on developing pro-regenerative siRNA therapies that enhance the body's natural healing processes. Their innovative approach targets intracellular barriers to repair, specifically silencing the FL2 enzyme to promote tissue and nerve regeneration. The company aims to provide effective treatment options fo... Read More
